⌘K

Login Start Free

Home/Filings/4/0001102624-13-000292

4//SEC Filing

Lewis Michael E 4

Accession 0001102624-13-000292

CIK 0001261734other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 8:42 PM ET

Size

11.9 KB

Accession

0001102624-13-000292

Insider Transaction Report

Form 4

Period: 2011-04-13

AEOLUS PHARMACEUTICALS, INC.AOLS

Lewis Michael E

Director

Transactions

Award
Non-qualified Stock Option (right to buy)
2011-11-07+11,250→ 11,250 total
Exercise: $0.40Exp: 2021-11-07→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-10-09+11,250→ 11,250 total
Exercise: $0.35Exp: 2022-10-09→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2011-04-13+11,250→ 11,250 total
Exercise: $0.50Exp: 2021-04-13→ Common Stock (11,250 underlying)
Award
Non-qualified Stock Option (right to buy)
2012-07-11+11,250→ 11,250 total
Exercise: $0.23Exp: 2022-07-11→ Common Stock (11,250 underlying)

Footnotes (1)

[F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeother

Related Parties

1

filerCIK 0001297065

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 8:42 PM ET
Size: 11.9 KB

View on SEC.gov